Home

/webconfig/uloziste/3376fdc9538cc60dbfec90f20b2e4718.png
/webconfig/uloziste/3376fdc9538cc60dbfec90f20b2e4718.png
/webconfig/uloziste/52d270b89854915181f382dd7afe3143.png
/webconfig/uloziste/1b147bb477057506febed78aa60fe6c6.png
/webconfig/uloziste/3a97bd2e176e17b5d4ca9a7590815843.jpg
/webconfig/uloziste/ab6b53e2e965efc55e176d29dd55de5b.jpg
/webconfig/uloziste/95ee918c8d46fb2cc4ebb1a56fbea671.png
/webconfig/uloziste/58ae44484569473ce603a00c7130de5f.png
/webconfig/uloziste/4c20c314638fe1ad90be8c4a52ab0f85.png
/webconfig/uloziste/24d13d4c3b9c20a7ab99df985ad6e60a.png

Introduction

Sickle cell disease (SCD) is a disorder due to faulty red blood cell function (hemoglobinopathy), and the most common life-threatening non-communicable disease in children in Africa, where most of these children die before adolescence. 

Bone marrow transplantation (BMT) is the only established cure, with over 90% success rates with a compatible family donor; it improves health-related quality of life (HRQoL) and is cost-effective. It is therefore justified medically, ethically and economically.

Drs Pietro Sodani connected to this project, is a leading expert in BMT for hemoglobinopathies. Has eradicating SCD around the world a top priority and leading efforts to translate research into cutting-edge therapies and cures and increase access to cure.

Do you know that the cure for blood cancer is in the hands of ordinary people? You could be the cure.

When you help us fundraise, you’re also helping patients get the support they need.

 

The content of this site may not be published in any way without written permission. © All rights reserved www.bmtghana.org